Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.
Exclusive Insights into the Prostate Cancer Population
Only found here from the AQUA Registry
Unique Understanding of Disease Progression
View prostate cancer biomarkers such as PSA level or Gleason score
Earlier View into the Prostate Cancer Patient Journey
Insight into treatment path choices from urologist EHRs
By the Numbers
Total patients with prostate cancer*
Total patients with prostate cancer with linked claims**
Average length of follow-up for total patients
*Defined as patients in AQUA Registry who have (1) either of the "Malignant neoplasm of prostate" ICD codes (ICD-9-CM 185 or ICD-10-CM C61); AND (2) a Gleason score of 6 or above.
**Year > 2015 linked with open or closed Komodo Health medical/pharmacy claims data with minimum 1 claim. Data Current to January 2023.
Meet with a Qdata Expert or Request a Data Count
Key Variables in Qdata Prostate Cancer
Curated variables are extracted from EHR data to be utilized based on your research needs.
Unstructured Data Enables Deeper Understanding
Verana Health applies clinician-informed algorithms to unstructured EHR data at scale to help extract key information on PSA levels, Gleason scores, castration resistance, and other key variables, which can then be analyzed across large populations in a reliable manner.
This can give life science companies unprecedented insights into the journey of patients with prostate cancer.
of Medical Data Remains Unstructured
Read More About Qdata Prostate Cancer
Check out research, blogs and news related to our work in prostate cancer.
Talk to a Qdata Expert
Take a minute to submit your contact information and one of our team members will reach out to you.